Table 1 Relationship between cuproptosis score and clinicopathological features of TARGET-neuroblastoma (NBL) dataset
Covariates | Total | High-score | Low-score | P-value |
|---|---|---|---|---|
No. (%) | No. (%) | |||
Age (years) | 1 | |||
≤ 10 | 140 (93.33%) | 63 (94.03%) | 77 (92.77%) | |
> 10 | 10 (6.67%) | 4 (5.97%) | 6 (7.23%) | |
Gender | 1 | |||
Female | 62 (41.33%) | 28 (41.79%) | 34 (40.96%) | |
Male | 88 (58.67%) | 39 (58.21%) | 49 (59.04%) | |
Status | 0.0005 | |||
Alive | 75 (50%) | 48 (71.64%) | 56 (67.47%) | |
Dead | 75 (50%) | 19 (28.36%) | 34 (40.96%) | |
COGRisk | 0.0005 | |||
High Risk | 119 (79.33%) | 40 (59.7%) | 79 (95.18%) | |
Intermediate Risk | 17 (11.33%) | 14 (20.9%) | 3 (3.61%) | |
Low Risk | 14 (9.33%) | 13 (19.4%) | 1 (1.2%) | |
TNM stage | 0.3058 | |||
II | 1 (0.67%) | 0 (0%) | 1 (1.2%) | |
III | 9 (6%) | 6 (8.96%) | 3 (3.61%) | |
IV | 140 (93.33%) | 61 (91.04%) | 79 (95.18%) |